Latest News

May 05, 2011
Yervoy, a new cancer drug that has been approved for the treatment of late-stage melanoma – and that is being used to treat other cancers in ongoing clinical trials – is based on a strategy for boosting the immune response developed and tested by scientists from UCSF and UC Berkeley.
April 26, 2011
Men and women had starkly different immune system responses to chronic post-traumatic stress disorder, with men showing no response and women showing a strong response, in two studies by researchers at the San Francisco VA Medical Center and the University of California, San Francisco.
April 05, 2011
Certain cases of major depression are associated with premature aging of immune cells, which may make people more susceptible to other serious illness, according to findings from a new UCSF-led study.
February 24, 2011
Among those cheering the recent opening of the new stem cell science building at UCSF were two patient advocates who have a personal connection to advancing the field of regenerative medicine.
February 16, 2011
Lewis Lanier, whose studies of cells of the immune system have caused textbooks to be rewritten and opened new avenues for exploring immunotherapies for a range of diseases, offered advice to young researchers during the 54th Faculty Research Lectureship in Basic Science at UCSF.
December 13, 2010
UCSF researchers have identified an existing medication that restores key elements of the immune system that, when out of balance, lead to a steady decline in immunity and health as people age.
November 23, 2010
University of California scholars will gather at UC Irvine on November 30 to showcase research aimed at improving the health of the world.
November 05, 2010
UCSF’s recent Bay Area Global Health Summit ignited robust discussion in hopes of stimulating ideas that lead to tangible progress toward advancing health worldwide™.
November 04, 2010
UCSF global health experts have outlined a new strategy and action plan to help countries eliminate malaria and bring the world closer to global eradication of the deadly disease.
October 29, 2010
The Lancet launched a special series on malaria elimination Oct. 29, led by the Global Health Group (GHG), a part of UCSF Global Health Sciences. The series included work by 36 authors worldwide, with guidance and support provided by a GHG-convened global advisory group of malaria experts, known as the Malaria Elimination Group.

Pages